Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin

被引：4
|
作者：
Biselli, M
Lorenzini, S
Gramenzi, A
Andreone, P
Bernardi, M
Rossi, C
Grazi, GL
机构：
[1] Univ Bologna, Dipartimento Med Interna, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Radiol, I-40138 Bologna, Italy
[3] Univ Bologna, Dept Surg, I-40138 Bologna, Italy
来源：
TRANSPLANTATION | 2004年 / 78卷 / 06期
关键词：
D O I：
10.1097/01.tp.0000135566.33051.35
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [1] An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
    Ogawa, Eiichi
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Dohmen, Kazufumi
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (05) : 689 - 697
  • [2] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [3] Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin
    Asahina, Y.
    Izumi, N.
    Umeda, N.
    Hosokawa, T.
    Ueda, K.
    Doi, F.
    Tsuchiya, K.
    Nakanishi, H.
    Matsunaga, K.
    Kitamura, T.
    Kurosaki, M.
    Uchihara, M.
    Higaki, M.
    Miyake, S.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (06) : 396 - 403
  • [4] Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy
    Bettoli, Vincenzo
    Mantovani, Lucia
    Boccia, Sergio
    Virgili, Annarosa
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (03) : 258 - 259
  • [5] High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence:: possible de novo autoimmune hepatitis?
    Berardi, S.
    Lodato, F.
    Gramenzi, A.
    D'Errico, A.
    Lenzi, M.
    Bontadini, A.
    Morelli, M. C.
    Tame, M. R.
    Piscaglia, F.
    Biselli, M.
    Sama, C.
    Mazzella, G.
    Pinna, A. D.
    Grazi, G.
    Bernardi, M.
    Andreone, P.
    GUT, 2007, 56 (02) : 237 - 242
  • [6] Clinical trials of pegylated interferon alpha-2b and ribavirin for patients with low hemoglobin and elderly patients
    Konishi, Ichiro
    Hiasa, Yoichi
    Nonaka, Suguru
    Joukou, Kouji
    Yamashita, Shogo
    Yamashita, Yoshimasa
    Ito, Yoshinobu
    Michitaka, Kojiro
    Horiike, Norio
    Onji, Morikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
  • [7] A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C Reply
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    HEPATOLOGY, 2014, 60 (06) : 2129 - 2129
  • [8] Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis
    Floreani, Annarosa
    Baldo, Vincenzo
    Rizzotto, Erik Rosa
    Carderi, Isabella
    Baldovin, Tatjana
    Minola, Eliseo
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) : 734 - 737
  • [9] The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
    Ogawa, Eiichi
    Furusyo, Norihiro
    Toyoda, Kazuhiro
    Takeoka, Hiroaki
    Maeda, Shinji
    Hayashi, Jun
    ANTIVIRAL RESEARCH, 2009, 83 (02) : 127 - 134
  • [10] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
12345